Pharmacokinetics and Safety of the MRI Contrast Agent Gadoversetamide Injection (Optimark) in Healthy Pediatric Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics and Safety of the MRI Contrast Agent Gadoversetamide Injection (Optimark) in Healthy Pediatric Subjects

Published:2004-06 Issue:6 Volume:39 Page:334-339
ISSN:0020-9996
Container-title:Investigative Radiology
language:en
Short-container-title:

Author:

Baker James F.,Kratz Linda C.,Stevens Gary R.,Wible James H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference18 articles.

1. Principals for design of liver contrast agents: liver imaging: current trends and new techniques.;Stark,1990

2. A review of contrast media research in 1999–2000.;Runge;Invest Radiol,2001

3. Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).;Grossman;Invest Radiol,1999

4. Toxicological Assessment of Gadoversetamide Injection (OptiMARK), a New Contrast-Enhancement Agent for Use in Magnetic Resonance Imaging.;Wible;Invest Radiol,2000

5. Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.;Swan;J Magn Reson Imaging,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monolacunary Wells-Dawson Polyoxometalate as a Novel Contrast Agent for Computed Tomography: A Comprehensive Study on In Vivo Toxicity and Biodistribution;International Journal of Molecular Sciences;2024-02-22

2. Methodological Aspects of Lymphatic Mapping: Radiopharmaceuticals, Multimodal Lymphatic Mapping Agents, Instrumentations;Atlas of Lymphoscintigraphy and Sentinel Node Mapping;2020

3. Safety and Monitoring for Cardiac Magnetic Resonance Imaging;Contemporary Cardiology;2019

4. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers;Chemical Reviews;2018-10-16

5. A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years;Investigative Radiology;2018-02